1
|
Gilis-Januszewska A, Rogoziński D, Nowak AJ, Piwońska-Solska B, Zygmunt-Górska A, Wójcik M, Starzyk J, Hubalewska-Dydejczyk A. Testing of Adrenal Axis Function in Patients With Combined Pituitary Hormone Deficiency Caused by PROP1 Mutation. J Endocr Soc 2021. [PMCID: PMC8090037 DOI: 10.1210/jendso/bvab048.1293] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
Abstract
Abstract
Background: The mechanism of adrenal axis deterioration in PROP1 mutation remains uncertain and challenging. Aim: The aim of the project was to investigate the adrenal axis function in patients with combined pituitary function deficiency and PROP1 mutation. Methods: We performed the corticotrophin (CRH) stimulation test in 15 patients ((8W/7M) with confirmed CPHD due to the PROP1 mutation. 9/15 were familial cases from four families. Time of observation (ToO) was calculated since the first pituitary axis/ACTH insufficiency has occurred. The results were reported in the group with confirmed Adrenal Insufficiency (AI) and without AI defined as cortisol >18 ug/dl at any point during CRH test. ACTH is reported in pg/ml and cortisol in ug/dl, time of test is given in minutes (0‘, 15’,30’,45’,60’,120’). Results: The mean age of the group was 40,6 ± 12,1 years with mean 34,7 ± 10,3 years of CPHD observation (range 18 – 54 years). The In 5/15 the cortisol response met the criteria excluding AI. Among siblings there were patients both with/without AI. Both subgroups had similar ToO (without AI 35,6 ± 10,0 years vs 34,2 ± 10,3 years with AI). Mean time of AI duration was 15,0 ± 9,3 years. In the group of 5 patients without AI the mean morning cortisol was 12,48 ± 4,31 and ACTH was 31,26 ± 5,43. The mean maximal concentration of cortisol and ACTH were 24,94 ± 3,6 and 123,6 ± 39,9 respectively; Mean increase of cortisol was 12,46 ±4,04 and 92,34±34,48 for ACTH. In 10 patients with AI the mean morning cortisol was 3,33±1,39 and ACTH 22,71±6,75. The mean maximal concentration of cortisol and ACTH were 10,15±4,47 and 97,05 ± 59,15 respectively; Mean increase of cortisol was 6,83 ± 3,41 and 74,35 ± 53,72 for ACTH. For two patients high ACTH increase from 36,7 to 260 and from 28,65 to 112,0 was observed. Analysis of cortisol and ACTH response in both groups revealed that in group without AI the time of peak of ACTH was observed in 15’ (2/5) and 30’ (3/5) vs. in 15’(3/10), 30’(6/10) and 45’ in group with AI. The peak cortisol was observed in 30’, 45’ and 60’ (3/5) in group without AI vs 60’(6/10) or 120’ (4/10) in AI group. The mean maximal increase of ACTH was by 4,09±1,46 and 4,12±1,58 in AI group vs no AI group respectively. Conclusions: In patients with PROP1 mutation the adrenal axis can deteriorate long after other axis insufficiencies, however there are patients with no adrenal insufficiency even during lifelong observation. There is no specific order of deterioration even among affected siblings. In the vast majority of patients independently of cortisol increase there is ACTH response after CRH. Further studies on the pituitary function deterioration in patients with PROP1 mutation should be carried out to understand better the underlying mechanism and to set up the diagnostic timing and procedures.
Collapse
Affiliation(s)
| | - Damian Rogoziński
- Department of Endocrinology, University Hospital in Cracow, Poland, Krakow, Poland
| | - Andrzej Jerzy Nowak
- Department of Endocrinology, University Hospital in Cracow, Poland, Krakow, Poland
| | | | - Agata Zygmunt-Górska
- Department of Paediatric and Adolescent Endocrinology, Chair of Paediatrics, Paediatric Institute, Jagiellonian University, Medical College, Kraków, Poland, Krakow, Poland
| | - Małgorzata Wójcik
- Department of Paediatric and Adolescent Endocrinology, Chair of Paediatrics, Paediatric Institute, Jagiellonian University, Medical College, Kraków, Poland, Krakow, Poland
| | - Jerzy Starzyk
- Department of Paediatric and Adolescent Endocrinology, Chair of Paediatrics, Paediatric Institute, Jagiellonian University, Medical College, Kraków, Poland, Krakow, Poland
| | | |
Collapse
|
2
|
Rogoziński D, Gilis-Januszewska A, Skalniak A, Kluczyński Ł, Pantofliński J, Hubalewska-Dydejczyk A. Pituitary tumours in MEN1 syndrome - the new insight into the diagnosis and treatment. Endokrynol Pol 2020; 70:445-452. [PMID: 31681967 DOI: 10.5603/ep.a2019.0026] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/16/2019] [Revised: 04/25/2019] [Accepted: 04/29/2019] [Indexed: 11/25/2022]
Abstract
Pituitary tumours are a common pathology affecting 15-20% of the population. Only about 1‰ of adenomas are clinically manifested; among them, about two/thirds are hormonally active, most often secreting prolactin or growth hormone. Pituitary tumours are mainly an isolated pathology, without any genetic background. However, the latest studies pay special attention to the possibility of developing an adenoma as a result of genetic mutation. Among pituitary adenomas, the leading group of genetically determined lesions is related to a mutation in AIP or MEN1, followed by PRKAR1A, GRP101, DICER, and SDHx. The genetic basis of these pituitary tumours is related to positive family history, young age of the patient, aggressive clinical process, and resistance to treatment. Pituitary tumours occur in over 40% of patients with MEN1 syndrome - often in women, they are more than 1 cm in diameter, and secrete prolactin. They are usually diagnosed in the fourth decade of life and show a worse response to pharmacotherapy than sporadic ones. Confirmation of the genetic background of the pituitary tumour implies measurable implications; it might help to direct the diagnosis in patients' family members, partially predict the development of the disease, and, above all, extend patients' life expectancy.
Collapse
Affiliation(s)
- Damian Rogoziński
- Endocrinology Department, University Hospital in Krakow, Krakow, Poland.
| | - Aleksandra Gilis-Januszewska
- Endocrinology Department, University Hospital in Krakow, Krakow, Poland.,Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
| | - Anna Skalniak
- Endocrinology Department, University Hospital in Krakow, Krakow, Poland.,Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
| | - Łukasz Kluczyński
- Endocrinology Department, University Hospital in Krakow, Krakow, Poland.,Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
| | | | - Alicja Hubalewska-Dydejczyk
- Endocrinology Department, University Hospital in Krakow, Krakow, Poland.,Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
| |
Collapse
|
3
|
Gilis-Januszewska A, Kluczyński Ł, Rogoziński D, Hubalewska-Dydejczyk A. Radiological and hormonal improvements in a 22-year-old patient with lymphocytic hypophysitis - the watchful waiting approach. Endokrynol Pol 2019; 71:104-105. [PMID: 31681974 DOI: 10.5603/ep.a2019.0046] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/02/2019] [Accepted: 10/06/2019] [Indexed: 11/25/2022]
Abstract
Not required for Clinical Vignette.
Collapse
Affiliation(s)
| | - Łukasz Kluczyński
- Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
| | - Damian Rogoziński
- Chair and Department of Endocrinology, Jagiellonian University Medical College, Krakow, Poland
| | | |
Collapse
|